Legal Representation
Attorney
Thomas A. Runk
USPTO Deadlines
Application History
18 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 12, 2008 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| May 24, 2006 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| May 24, 2006 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Sep 19, 2005 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 19, 2005 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Sep 19, 2005 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Sep 6, 2005 | I | PAPER RECEIVED | Loading... | |
| May 20, 2005 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 21, 2005 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 21, 2005 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Sep 21, 2004 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 29, 2004 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 9, 2004 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Apr 24, 2004 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 24, 2003 | I | PAPER RECEIVED | Loading... | |
| Nov 24, 2003 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 14, 2003 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 23, 2003 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 035
Business consultation with pharmacies and medical practices, namely, analysis of failure modes and effects in critical intravenous drug administration, evaluation of high risk processes and technologies in intravenous drug administration, evaluation and optimization of workflow and clinical processes in intravenous drug administration, analysis of medication safety systems, and re-engineering of business practices concerning medication safety systems and continuous quality improvement
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
Medical drug research services, namely, analysis of failure modes and effects in critical intravenous drug administration, evaluation of high risk processes and technologies in intravenous drug administration, evaluation and optimization of workflow and clinical processes in intravenous drug administration, and analysis of medication safety systems to ensure quality improvement
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
035
044